Diabetes News and Research

Latest Diabetes News and Research

Ampio Pharmaceuticals starts Optina clinical trial

Ampio Pharmaceuticals, Inc. announced oral dosing of the first patient in a 505(b)(2) clinical trial of the investigational drug Optina in diabetic macular edema.

27 Feb 2013

Study shows people of high socioeconomic status more likely to get access to primary care

People of high socioeconomic status are more likely to be able to access primary care than those of low socioeconomic status, even within a universal health care system in which physicians are reimbursed equally for each patient, found an article published in CMAJ.

27 Feb 2013

Researchers to discuss health issues at Society of Toxicology's Annual Meeting and ToxExpo

Researchers will meet at the Society of Toxicology's Annual Meeting and ToxExpo March 10-16 to discuss a number of health concerns that have received growing public attention over the past several months.

27 Feb 2013

Offices of family physicians appear to give preference to people with chronic health conditions

Some family physicians' offices discriminate against people of low socio-economic status, even when there is no economic incentive to do so under Canada's system of publicly funded universal health insurance, new research has shown.

27 Feb 2013

XBiotech to enter biosimilar business

XBiotech, a privately held biotechnology company, announced today that it is entering the biosimilar business. The Company is launching its biosimilar business with development of two of the world's leading therapeutic antibodies, one an oncology and the other an anti-inflammatory product.

26 Feb 2013

COPD benzodiazepine warning

Canadian researchers have found that benzodiazepines are frequently prescribed for patients with chronic obstructive pulmonary disease (COPD), despite their known association with adverse respiratory outcomes.

26 Feb 2013

Cardiometabolic risk prevention opportunity in early schizophrenia

esearchers have found that cardiometabolic risk in patients with schizophrenia is heightened in those with established disease, suggesting a need for early intervention in those presenting with their first episode.

26 Feb 2013

Ill health more likely to be responsible for retirement in regional areas than in cities

Men and women of working age, living in regional areas are more likely to be fully retired because of ill health than their city counterparts, University of Sydney research shows.

26 Feb 2013

Research roundup: Patients hesitant to focus on costs; Increase in primary care demand is uneven

One way to contain health care spending is to get patients involved in weighing costs of treatment options with their doctors. Researchers recruited 211 medically insured participants to assess their willingness to consider costs when choosing treatments. The authors found that participants generally "preferred better care, even when the relative benefit it offered was marginal, and even when told that the second-best choice still met the threshold of 'good enough' care from a clinician's perspective.

26 Feb 2013

Avaxia initiates AVX-470 Phase 1b clinical study in ulcerative colitis

Avaxia Biologics, Inc., a clinical-stage biopharmaceutical company developing gut-targeted therapeutics, announced today that the first patient has been dosed in a Phase 1b clinical study of AVX-470, an oral anti-TNF antibody, for the treatment of ulcerative colitis.

25 Feb 2013

WOEST supports clopidogrel only in PCI patients on anticoagulation

Publication of the WOEST trial results reaffirm the study’s major finding that antiplatelet therapy with clopidogrel alone is preferable to the use of both aspirin and clopidogrel in patients undergoing percutaneous coronary intervention who are receiving oral anticoagulant therapy.

25 Feb 2013

Antioxidant boosts liver transplant outcomes

Infusion of N-acetylcysteine in liver donors can significantly improve the outcome of transplantation, research shows.

25 Feb 2013

CT angiography uncovers cardiovascular disease risk

Computed tomography angiography can warn of the likelihood for major adverse cardiovascular events in patients suspected of having coronary artery disease in the absence of medically modifiable risk factors, research shows.

25 Feb 2013

CHADS scores possibilities extend beyond atrial fibrillation

The CHADS-based risk scores can predict long-term vascular outcomes and mortality in patients with stroke who do not have atrial fibrillation, research suggests.

25 Feb 2013

Community health team improves diabetes control in Polynesian community

A team of community health workers has been able to improve control of Type 2 diabetes in a group of individuals from American Samoa – a medically underserved territory with a high prevalence of obesity, diabetes, and other cardiovascular risk factors, report researchers.

25 Feb 2013

Diabetes News and Research

Latest Diabetes News and Research

Ampio Pharmaceuticals starts Optina clinical trial

Study shows people of high socioeconomic status more likely to get access to primary care

Researchers to discuss health issues at Society of Toxicology's Annual Meeting and ToxExpo

Offices of family physicians appear to give preference to people with chronic health conditions

XBiotech to enter biosimilar business

COPD benzodiazepine warning

Cardiometabolic risk prevention opportunity in early schizophrenia

Ill health more likely to be responsible for retirement in regional areas than in cities

Research roundup: Patients hesitant to focus on costs; Increase in primary care demand is uneven

Avaxia initiates AVX-470 Phase 1b clinical study in ulcerative colitis

WOEST supports clopidogrel only in PCI patients on anticoagulation

Antioxidant boosts liver transplant outcomes

CT angiography uncovers cardiovascular disease risk

CHADS scores possibilities extend beyond atrial fibrillation

Community health team improves diabetes control in Polynesian community

Heightened stroke risk for patients with sleep apnea and atrial fibrillation

Gender bias detected for hip arthroplasty failure

Opioids are main contributor to fatal overdoses

Protamine–heparin complex antibodies raise concerns

GLP-1 may increase risk of hospitalization for people with acute pancreatitis

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in